Navigation Links
Afraxis, Inc. and Servier Announce a Collaboration on ESP Platform for Drug Discovery in Central Nervous System Disorders
Date:4/30/2013

SAN DIEGO and PARIS, April 30, 2013 /PRNewswire/ -- Afraxis, Inc. ("Afraxis") and Institut de Recherches Servier ("Servier") announced a non-exclusive platform collaboration using Afraxis' Enhanced Spine Platform (ESP) Technology for the discovery of drugs to treat central nervous system (CNS) disorders.  Afraxis' ESP Technology rapidly assesses complex neural networks to evaluate preclinical efficacy and safety in CNS disorders. The technology quantifies and characterizes the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing in the brain. Financial terms have not been disclosed.

"Servier is committed to bringing new medicines for the treatment of a variety of CNS diseases and disorders," said Dr. Emmanuel Canet , President of Servier Research & Development. "We recognize that Afraxis is a global leader in dendritic spine analysis which provides a sophisticated and quantifiable read-out on neuroprotection."

Dr. Christian de Bodinat, Director of CNS Research & Development added, "The ESP Technology will allow Servier to fully investigate the broad potential of our drug candidates with the aim of bringing novel medicines into the clinic more rapidly and with greater certainty of action. Servier is very active in the field of neurology with two potential first-in-class compounds in Phase II studies in Alzheimer Disease and five other compounds aimed at treating neurodegenerative diseases in late preclinical stages."

The Afraxis ESP Technology is highly adaptable to many CNS disease models and can be used to characterize disease profiles, assess preclinical drug efficacy, identify optimal dosing routines, or identify undesirable CNS side effects. 

"Servier has a strong commitment to CNS therapeutics, and their interest in the ESP Technology further illustrates the potential of this p
'/>"/>

SOURCE Afraxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. NextBio Announces Translational Medicine Partnership with Sanofi
2. Collegium Announces Results of Chronic Pain Patient Survey - Confirms Significant Unmet Medical Need for a Differentiated, Abuse-Deterrent, Extended-Release Opioid
3. IRIDEX Announces Receipt of Large Orders for Laser Systems from Developing Countries
4. Kewaunee Scientific Announces CEO Retirement and Appointment of Successor
5. Blue Belt Technologies Announces Formation of Hip Scientific Advisory Board for Development of Next NavioPFS Application for Femoroacetabular Impingement
6. FDAnews Announces Medical Device Risk Management Conference, July 11-12, 2013, Boston, MA
7. Cannabis Science announces preclinical development program for CS-TATI-I, commencing EU operations in the Netherlands and sourcing proprietary material for pharmacokinetic characterization
8. Simcere Pharmaceutical Group to Announce First Quarter 2013 Financial Results on Thursday, May 9, 2013
9. ConvaTec Announces 2012 Year-End Earnings Call
10. Cumberland Pharmaceuticals To Announce First Quarter 2013 Financial Results On May 2, 2013
11. Auxilium Pharmaceuticals to Announce First Quarter 2013 Results and Conduct Conference Call on Monday, April 29, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... -- Indianapolis interventional medical device maker NICO Corporation ... visualization leader Synaptive Medical announced today ... that they have joined forces to integrate their ... the first of its kind and will make ... BrainPath® interventional access technology and Synaptive,s BrightMatter™ real-time ...
(Date:10/20/2014)...  AnaptysBio, Inc., a leader in the discovery ... appointment of Marco Londei , M.D. as ... preclinical and clinical development of AnaptysBio,s proprietary antibody ... welcome Dr. Londei to AnaptysBio,s executive leadership team," ... Executive Officer of AnaptysBio. "Dr. Londei,s extensive expertise ...
(Date:10/20/2014)... -- Norgine B.V. today announced that the ... preparation, NER1006, presented at the 79 th Annual ... Philadelphia, PA , has met its ... endpoint of cleansing success. The study demonstrated high quality ... in screening colonoscopy patients. [1] (Logo: ...
Breaking Medicine Technology:Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2
... 2011 The Radiosurgery Society™ (RSS), a non-profit organization ... clinical practice of stereotactic body radiotherapy (SBRT) and radiosurgery ... at the La Costa Resort in Carlsbad, Calif.   ... Radiosurgery Society has been expanded to serve as a ...
... To reward loyal shoppers, CVS/pharmacy today ... multiple free gift cards just by shopping for essentials ... began on Sunday October 16 and will go through ... can earn $10 gift cards to Macy,s, Gap, Applebee,s, ...
Cached Medicine Technology:Announcing The Radiosurgery Society™ And Its 2012 SRS/SBRT Scientific Meeting 2Announcing The Radiosurgery Society™ And Its 2012 SRS/SBRT Scientific Meeting 3Save Big This Fall with CVS/pharmacy's Free Gift Cards Promotion 2Save Big This Fall with CVS/pharmacy's Free Gift Cards Promotion 3
(Date:10/20/2014)... Principle Business Enterprises, a family owned ... top-of-the-line absorbent products. The company has recently made ... brand, Tranquility® Premium Protection absorbent products. The company ... its packaging a new look, and is currently working ... the public. , The new website, developed with Thread ...
(Date:10/20/2014)... PA (PRWEB) October 20, 2014 ... Matthew Voicheck as Assistant Director of their ... role in managing the innovative turnkey drug sourcing, ... , Matthew brings over 12 years of industry ... joins Myoderm at the peak of their international ...
(Date:10/20/2014)... Succeed is proud to announce that they ranked ... the Every Body Walk! campaign by Kaiser Permanente. ... encourages workers to be more active outside of the workplace. ... at the end of September, was a friendly competition between ... Participating companies gave their staff pedometers and each day, ...
(Date:10/20/2014)... 2014 National Teen Driver Safety Week is ... Academy of Pediatrics (Ohio AAP, http://www.ohioaap.org ) is joining ... of teen drivers to talk to their teens and always ... vehicle crashes are the leading cause of death for U.S. ... fatal crashes, and 859 (42%) of those teen drivers were ...
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, The Center ... hospital ROI on membership dues at 12.5. In other words, ... in value to member hospitals. The calculation used to determine ... , “This is the first time we’ve actually been ... methodology is really sound,” said Bill Ryan , president ...
Breaking Medicine News(10 mins):Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4
... River Valley Water Supply Project's key agenda is to transfer ... heavily populated areas in the red river drainage basin. // ... proposition, due to a perceptible risk of foreign biota filling ... of the Earth Canada, feels that a task of such ...
... pneumonia, bronchitis and other infections. Bristol-Myers Squibb Co. (BMY) ... Food and Drug Administration said that the drug would ... blood-sugar changes due to this drug. ,This ... serious cases of hypoglycemia (low blood sugar) and hyperglycemia ...
... Ranbaxy has introduced a diagnostic test for Bird Flu that ... accurate results within 24 hours. Named as RT-PCR test, // ... be available in a day. Certainly a blessing in the ... available to check for Bird Flu report results only after ...
... of dance lovers in discos has been found to work ... was first synthesised in 1910. It was patented two years ... suppressant. ,The study finds that loud music exacerbates ... was conducted by Italian scientists on rats. Who were given ...
... on either couple, men seem to be more vulnerable, according ... his research team from Harvard Medical School. ,The ... the risk of illness in the other partner in a ... ,They found that when a spouse was hospitalized, ...
... Medicines Racket is growing at alarming proportions. The United Nations ... wide initiative , by way of a task force team ... of counterfeit drugs. A three day meeting is underway in ... - Pharamaceutical companies, Regulatory bodies and groups which represent the ...
Cached Medicine News:Health News:The effects of Ecstasy more pronounced in presence of music 2
Straight 9 mm downcutting Royce blade. Can be placed in closed handle for protection. Handle length folded 109 mm, 4.3 inches. Blade can be set automatically and rigidly at any point from straight to...
Duckbill. 3.5 mm tip. Light curve....
Duckbill type, sharp. 3 mm x 8 mm curved blade. Octagonal handle....
4 mm x 9 mm tip....
Medicine Products: